Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Patients received a 2-week lead-in of ulixertinib monotherapy at 600, 450, or 300 mg twice a day (fasting) using a modified Fibonacci design, followed by combination treatment with GnP (gemcitabine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results